Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.

Hamid R, Loyd J.

Eur Respir J. 2012 Jun;39(6):1292-3. doi: 10.1183/09031936.00218911. No abstract available.

2.

Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.

Frydman N, Steffann J, Girerd B, Frydman R, Munnich A, Simonneau G, Humbert M.

Eur Respir J. 2012 Jun;39(6):1534-5. doi: 10.1183/09031936.00185011. No abstract available.

3.

[Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].

Fujiwara M, Yagi H, Matsuoka R, Saji T.

Nihon Rinsho. 2008 Nov;66(11):2071-5. Review. Japanese.

PMID:
19051722
4.

BMPR2 mutation and outcome in pulmonary arterial hypertension: clinical relevance to physicians and patients.

Rubin LJ.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1300-1. doi: 10.1164/rccm.200804-495ED. No abstract available.

PMID:
18522952
5.

Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension.

Souza R, Fernandes CJ, Hoeper MM.

Eur Respir J. 2014 Apr;43(4):963-5. doi: 10.1183/09031936.00024114. No abstract available.

6.

Update in pulmonary arterial hypertension 2007.

Humbert M.

Am J Respir Crit Care Med. 2008 Mar 15;177(6):574-9. doi: 10.1164/rccm.200801-029UP. Review. No abstract available.

PMID:
18316769
7.

Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.

Fujiwara M, Yagi H, Matsuoka R, Akimoto K, Furutani M, Imamura S, Uehara R, Nakayama T, Takao A, Nakazawa M, Saji T.

Circ J. 2008 Jan;72(1):127-33.

8.

Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.

Machado RD.

Eur Respir J. 2012 Feb;39(2):235-7. doi: 10.1183/09031936.00190011. No abstract available.

9.

Genetics of pulmonary arterial hypertension: current and future implications.

Elliott CG.

Semin Respir Crit Care Med. 2005 Aug;26(4):365-71. Review.

PMID:
16121312
10.
11.

Genes and pulmonary arterial hypertension.

Sztrymf B, Yaïci A, Girerd B, Humbert M.

Respiration. 2007;74(2):123-32. Review.

PMID:
17318011
12.

Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.

Yang J, Davies RJ, Southwood M, Long L, Yang X, Sobolewski A, Upton PD, Trembath RC, Morrell NW.

Circ Res. 2008 May 23;102(10):1212-21. doi: 10.1161/CIRCRESAHA.108.173567. Epub 2008 Apr 24.

13.

Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension.

Phillips JA 3rd, Poling JS, Phillips CA, Stanton KC, Austin ED, Cogan JD, Wheeler L, Yu C, Newman JH, Dietz HC, Loyd JE.

Genet Med. 2008 May;10(5):359-65. doi: 10.1097/GIM.0b013e318172dcdf.

PMID:
18496036
14.

BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.

Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA.

Am J Med Genet A. 2008 Oct 1;146A(19):2551-6. doi: 10.1002/ajmg.a.32468.

PMID:
18792970
15.

Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.

Roberts KE, Barst RJ, McElroy JJ, Widlitz A, Chada K, Knowles JA, Morse JH.

Chest. 2005 Dec;128(6 Suppl):618S. No abstract available.

PMID:
16373874
16.

Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.

Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, Diamond B, Barst RJ.

J Heart Lung Transplant. 2008 Jun;27(6):668-74. doi: 10.1016/j.healun.2008.02.009. Epub 2008 Apr 9.

PMID:
18503968
17.

Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension.

Trip P, Girerd B, Bogaard HJ, de Man FS, Boonstra A, Garcia G, Humbert M, Montani D, Vonk-Noordegraaf A.

Eur Respir J. 2014 Apr;43(4):1195-8. doi: 10.1183/09031936.00136413. Epub 2013 Sep 13. No abstract available.

18.

Pulmonary hypertension for clinicians: time to call on genetics?

Reichenberger F.

Respiration. 2010;79(4):274-5. doi: 10.1159/000264922. Epub 2009 Dec 7. No abstract available.

19.

A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.

Fu LJ, Zhou AQ, Huang MR, Shen SH, Shen J, Zhang ZF, Li F.

Chin Med J (Engl). 2008 Mar 5;121(5):399-404.

PMID:
18364108
20.

[Primary pulmonary hypertension].

Otsuka F, Makino H.

Nihon Rinsho. 2005 Oct;63 Suppl 10:450-7. Review. Japanese. No abstract available.

PMID:
16279681

Supplemental Content

Support Center